250 related articles for article (PubMed ID: 7872342)
1. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
[TBL] [Abstract][Full Text] [Related]
4. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
Díez J; Laviades C
J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
Almeida P; Azevedo A; Rodrigues R; Dias P; Friões F; Vazquez B; Abreu-Lima C; Bettencourt P; Barros H
Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
8. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
11. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
Rubattu S; Sciarretta S; Ciavarella GM; Venturelli V; De Paolis P; Tocci G; De Biase L; Ferrucci A; Volpe M
J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
[TBL] [Abstract][Full Text] [Related]
12. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension.
Irzmanski R; Barylski M; Banach M; Piechota M; Kowalski J; Cierniewski C; Pawlicki L
Med Sci Monit; 2007 Oct; 13(10):CR449-56. PubMed ID: 17901852
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy.
Kohno M; Minami M; Kano H; Yasunari K; Maeda K; Hanehira T; Yoshikawa J
Metabolism; 2000 Oct; 49(10):1356-60. PubMed ID: 11079829
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
Soualmia H; Ayadi I; Omar S; Feki M; Drissa H; Mebazaa A; Kaabachi N
Clin Lab; 2009; 55(3-4):120-7. PubMed ID: 19462934
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
16. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
[TBL] [Abstract][Full Text] [Related]
17. [Plasma levels of atrial and brain natriuretic peptide and left ventricular geometry in patients with essential hypertension].
Kosmala W; Spring A
Pol Merkur Lekarski; 2003 Mar; 14(81):216-9. PubMed ID: 12914098
[TBL] [Abstract][Full Text] [Related]
18. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
Brilla CG; Rupp H; Maisch B
Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
[TBL] [Abstract][Full Text] [Related]
19. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
Ovchinnikov AG; Serbul VM; Ageev FT
Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
[TBL] [Abstract][Full Text] [Related]
20. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
